Get the Stockscreener App
7.31
3.98%
0.28
After Hours:
3.43
-3.88
-53.08%
Mimedx Group Inc stock is traded at $7.31, with a volume of 1.08M.
It is up +3.98% in the last 24 hours and up +8.14% over the past month.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$7.03
Open:
$7.13
24h Volume:
1.08M
Relative Volume:
1.47
Market Cap:
$1.08B
Revenue:
$342.81M
Net Income/Loss:
$97.67M
P/E Ratio:
11.90
EPS:
0.6145
Net Cash Flow:
$50.46M
1W Performance:
+2.81%
1M Performance:
+8.14%
6M Performance:
-8.40%
1Y Performance:
+11.09%
1-Day Range:
$7.09
$7.39
1-Week Range:
$7.01
$7.39
52-Week Range:
$5.47
$10.14
Mimedx Group Inc Stock (MDXG) Company Profile
Name
Mimedx Group Inc
Sector
Industry
Phone
(770) 651-9100
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.92 | 1.26B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.58 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.53 | 110.24M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1668 | 351.80M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.24 | 0 | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-02-24 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-24 | Initiated | Lake Street | Buy |
| Oct-27-23 | Initiated | Craig Hallum | Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-26-21 | Initiated | Northland Capital | Outperform |
| Mar-19-21 | Initiated | H.C. Wainwright | Buy |
View All
Mimedx Group Inc Stock (MDXG) Latest News
MiMedx Group Inc. stock trend outlook and recovery pathJuly 2025 News Drivers & Safe Swing Trade Setup Alerts - Newser
Is MiMedx Group Inc. stock entering bullish territorySwing Trade & Expert Verified Stock Movement Alerts - Newser
Evaluating MiMedx Group Inc. with trendline analysisJuly 2025 Earnings & Reliable Volume Spike Alerts - Newser
Why MiMedx Group Inc. is moving todayMarket Trend Report & Long-Term Capital Growth Ideas - Newser
Real time breakdown of MiMedx Group Inc. stock performanceEarnings Miss & Daily Volume Surge Trade Alerts - Newser
Sector ETF performance correlation with MiMedx Group Inc.2025 Buyback Activity & Free Safe Capital Growth Stock Tips - Newser
How to escape a deep drawdown in MiMedx Group Inc.Trade Risk Assessment & Consistent Growth Equity Picks - Newser
How MiMedx Group Inc. stock performs during market volatilityTrade Volume Report & Daily Market Momentum Tracking - Newser
Can MiMedx Group Inc. rally from current levelsMarket Rally & Verified Chart Pattern Signals - Newser
What makes MiMedx Group Inc. stock price move sharplyEarnings Performance Report & Free Community Supported Trade Ideas - Newser
Tools to monitor MiMedx Group Inc. recovery probabilityWeekly Earnings Recap & Long-Term Investment Growth Plans - Newser
Does MiMedx Group Inc. have consistent dividend growthJuly 2025 PostEarnings & Long-Term Investment Growth Plans - kangso.co.kr
Is MiMedx Group Inc. trending in predictive chart modelsJuly 2025 Gainers & Growth Focused Entry Reports - Newser
Is MiMedx Group Inc. stock heavily shortedQuarterly Profit Summary & Fast Gaining Stock Reports - newsyoung.net
US Ophthalmology Amniotic Membrane Market to Reach $7.35B - openPR.com
Can you recover from losses in MiMedx Group Inc.AI Swing Strategy Signal Forecasting System - Newser
Zurcher Kantonalbank Zurich Cantonalbank Acquires 6,090 Shares of MiMedx Group, Inc (NASDAQ:MDXG) - Defense World
Full technical analysis of MiMedx Group Inc. stockAsset Safety Selection Using Quantitative Analysis - Newser
There May Be Reason For Hope In MiMedx Group's (NASDAQ:MDXG) Disappointing Earnings - Yahoo Finance
Clover Health and MiMedx Group Receive Bullish Analyst Sentiments - AInvest
Why MiMedx Group Inc. stock attracts strong analyst attentionShort Term High Yield Stock Tips for Active Traders - metal.it
Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and MiMedx Group (MDXG) - The Globe and Mail
MiMedx Group Inc. Reports Record Earnings and Growth - TipRanks
MiMedx raises full-year revenue growth outlook to low double digits as momentum builds post-record quarter - MSN
Is MiMedx Group Inc. a good long term investmentFree Consultation - Jammu Links News
What drives MiMedx Group Inc. stock priceBuild wealth faster with consistent investment plans - Jammu Links News
Published on: 2025-08-04 04:52:32 - Jammu Links News
What are analysts’ price targets for MiMedx Group Inc. in the next 12 monthsHigh-yield investments - Jammu Links News
MiMedx Group Inc. Stock Analysis and ForecastCapitalize on stocks with high profit margins - Jammu Links News
When is MiMedx Group Inc. stock expected to show significant growthAchieve breakthrough financial results - Jammu Links News
Should I hold or sell MiMedx Group Inc. stock in 2025Consistently superior profits - Jammu Links News
What institutional investors are buying MiMedx Group Inc. stockCapitalize on high-yield stock opportunities - Jammu Links News
How does MiMedx Group Inc. generate profit in a changing economyHarness the power of proven investment plans - Jammu Links News
What catalysts could drive MiMedx Group Inc. stock higher in 2025Free Investment Community - Jammu Links News
What is the dividend policy of MiMedx Group Inc. stockAchieve fast wealth growth with smart picks - Jammu Links News
Is it the right time to buy MiMedx Group Inc. stockMaximize gains with data-driven stock picks - Jammu Links News
What are the latest earnings results for MiMedx Group Inc.Achieve explosive financial results today - Jammu Links News
What is the risk reward ratio of investing in MiMedx Group Inc. stockAchieve breakthrough results with expert guidance - Jammu Links News
MiMedx Exceeds Q2 Revenue Expectations with Double-Digit Growth, Achieving Highest Quarterly Net Sales to Date. - AInvest
MiMedx Q2 2025 Earnings: EPS of $0.06 Beats Estimates, Revenue Hits $99 Million Surpassing Projections - AInvest
MiMedx Group Anticipates Improved EBITDA Margin for FY25, Projects Low Double-Digit Annual Net Sales Growth - AInvest
MiMedx Group, Inc. (NASDAQ:MDXG) Q2 2025 Earnings Call Transcript - Insider Monkey
MiMedx Group Reports Record Q2 2025 Financial Results - The Globe and Mail
MiMedx Group Inc. Achieves Impressive Q2 Financial ResultsNews and Statistics - IndexBox
Mimedx Group Inc Stock (MDXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mimedx Group Inc Stock (MDXG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Maersk-Moller Kimberly | Chief Commercial Officer |
Mar 17 '25 |
Sale |
8.04 |
1,759 |
14,142 |
309,077 |
| Hulse William Frank IV | General Counsel and CAO |
Mar 13 '25 |
Sale |
7.89 |
54,596 |
430,762 |
440,178 |
| Maersk-Moller Kimberly | Chief Commercial Officer |
Mar 13 '25 |
Sale |
7.89 |
4,106 |
32,396 |
310,836 |
| Hulse William Frank IV | General Counsel and CAO |
Mar 10 '25 |
Sale |
7.80 |
81,446 |
635,279 |
494,774 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):